Investors in life science

Scroll

Leadership in life science investing

Working out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Our mission is to be a supportive owner of the Novo Group companies and to make a growing and positive impact on health, science and society by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.

Holdings and investments

We are the holding company of the Novo Group and manage the investment assets of the Novo Nordisk Foundation. We invest in life science companies at all stages of development and in a broad portfolio of equity and fixed income securities.

Our people embrace a culture of high performance with high responsibility

Novo Holdings employs over 80 investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.

Annual review

Selected key figures

  • 48 bn

    Total assets of Novo Holdings at the end of 2017.

  • 21 %

    Return on Life Science investments (IRR) last 5 years.

  • 11 %

    Return on Financial investments (IRR) last 5 years.

Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
Denmark
+45 3527 6500

CVR# 24257630

Novo Ventures (US) Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02142
USA

Novo Ventures (US) Inc.*
501 2nd Street, Suite 300
San Francisco, CA 94107
USA

+1 (415) 552-6686

*Novo Ventures (US) Inc. is a separate legal entity that provides certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more